23 Jul, 2026
According to Straits Research, the global fluoroscopy devices market size was valued at $5.53 billion in 2025 and is projected to grow from $5.8 billion in 2026 to $8.51 billion by 2034 at a CAGR of 4.91% during the forecast period 2026-2034.
Fluoroscopy is an enhanced X-ray technology that generates moving images of an object on a television-like screen or monitor. It is mainly used for imaging the gastrointestinal tract to detect clinical issues such as tumors, ulcers, inflammation, obstructions, etc. Increasing applications in clinical diagnostics, the rising need for less invasive operations, technical developments, and its application for multiple medical conditions are the primary factors driving the fluoroscopy devices market. Over the past decade, the prevalence of numerous chronic diseases has climbed considerably globally. The threat posed by these diseases to public health has increased substantially, leading to the adoption of new diagnostic procedures and expanding the market.
Minimally invasive surgery refers to any surgical treatment conducted through small incisions instead of large ones. Recent studies indicate a growing desire for single or minor incision operations as an alternative to conventional procedures. Moreover, the numerous advantages of minimally invasive procedures, such as reduced surgical discomfort, injury, scarring, hospital stay, improved accuracy, and faster recovery time, encourage more patients to choose minimally invasive balloon angioplasty procedures. According to the American College of Cardiology, around 1.2 million angioplasties were performed annually in the United States in 2020.
In addition, some doctors have begun performing these minimally invasive treatments in their clinics, which may be a contributing cause to the market's growth. Medicare reports that in 2018, the United States spent around $4.9 billion on ambulatory surgery facilities. Moreover, in the United States, the Agency for Healthcare Research and Quality (AHRQ) is committed to enhancing ambulatory care safety and quality and promoting market expansion. The market growth may be boosted in light of the abovementioned situations and the increasing demand for minimally invasive surgeries to treat cardiovascular illnesses over the past several years.
As part of their pain treatment plan, fluoroscopy enables pain management professionals to check specific bodily components, such as vertebral or skeletal regions. The patient is positioned between an X-ray source and a fluorescent screen.
A 2018 study titled "What is the role of fluoroscopy in the performance of therapeutic injections for pain management?" concluded that "fluoroscopy has transformed interventional pain management, not only for more precise needle placement but also for exploring new treatment venues, particularly within the spinal canal." The ability to treat different spinal pain generators using injections of radiographic contrast, local anesthetics, and corticosteroids into the epidural space, sacroiliac joints, intra-articular facet joints, and intervertebral discs demonstrates the expansion of the market.
In addition, according to a 2018 study titled 'Image Guidance Technologies for Interventional Pain Procedures: Ultrasound, Fluoroscopy and CT,' patients with uncontrolled chronic pain may benefit from spinal injections and nerve blocks. Interventional procedures have evolved and improved throughout time. The advancement of image-guided technologies plays a significant role in enhancing these operations. Image guiding has significantly improved the accuracy and safety of these procedures. The first image-guided technology utilized by pain specialists was fluoroscopy, and this condition may drive the market in the future.
North America accounts for the largest market share and is estimated to grow at a CAGR of 5.7% during the forecast period. The United States is home to many medical technology businesses and market leaders active in product releases, consequently boosting the market's breadth. In November, FUJIFILM Medical Systems USA Inc., a significant producer of diagnostic imaging and medical informatics solutions, unveiled two new systems, the Persona C Surgical C-Arm and the Persona RF PREMIUM System 2020. These systems may provide digital X-ray imaging studies and fluoroscopy exams, enabling physicians to increase productivity and evaluate patient conditions. The strategic transaction broadened the company's offering of medical imaging products. Such advancements are anticipated to stimulate the creation of more innovative fluoroscopes, consequently contributing to market expansion.
Europe is estimated to reach an expected value of USD 1,680 million, registering a CAGR of 6% during the forecast period. The major contributors to the expansion of the fluoroscopy market in Germany are the increasing occurrences of chronic illnesses, the growing preference for minimally invasive surgery, the growing elderly population, and several industry participants' execution of strategic initiatives. The Federal Statistical Office (Destatis) projects that between 2020 and 2035, the number of people aged 67 or older will increase by 22%, from 16 million to 20 million. These projections are based on data from the Statistisches Bundesamt (Destatis) for 2021. The increasing senior population in Germany will increase the demand for fluoroscopes due to chronic diseases among the elderly.
Asia-Pacific is the third-largest region. Fluoroscopy's expansion in China is primarily driven by the increasing frequency of cardiovascular illnesses, the rising elderly population, rising fluoroscopy-related research and development, and improving healthcare infrastructure. China has one of the fastest-growing aging populations, as the World Health Organization (WHO) estimated in 2021. The proportion of its population over 60 years old is anticipated to reach 28% by 2040. This indicates that as China's senior population grows, the prevalence of cardiovascular diseases will increase, and a substantial population will undergo fluoroscopy operations involving the heart septum, appendage, and valves. In addition, the increasing preference for minimally invasive surgery in China is a significant factor in the country's high demand for fluoroscopy instruments.
sales@straitsresearch.com